Form D · Biotechnology
Allovir, Inc.
Houston, TX · CIK 0001754068
Offering snapshot reported May 22, 2019 · SEC filing
- Reported sold
- $121M Offering amount: $121M
- Investors reported
- 47 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 8, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 22, 2019 | Initial | $121,253,231 | No comparison | 47 | SEC filing |
| Oct 2, 2018 | Initial | $30,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-340180
Amount sold shown in item 13 and number of investors shown in item 14 includes $28,999,982 from 3 non-US investors.
Source: Form D, filed May 22, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Malcom Brenner | Director |
| Ansbert Gadicke | Director |
| David Hallal | Director, Executive |
| Morana Jovan Embiricos | Director |
| Vikas Sinha | Director, Executive |
| Juan Vera | Director |
| John Wilson | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2925 Richmond Ave. Suite 1274
Houston, TX, 77098
Houston, TX, 77098